Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Urology

• Publication date

  2003-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.JU.0000074747.72993.CBPMID 12853777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens.

  2002cited by this paper
• The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies.

  2001cited by this paper
• The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.

  2000cited by this paper
• Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a Gleason score ≤ 7

  2000cited by this paper
• Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up.

  1998cited by this paper
• Ability of sextant biopsies to predict radical prostatectomy stage.

  1998cited by this paper
• Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.

  1997cited by this paper
• Increasing incidence of minimal residual cancer in radical prostatectomy specimens.

  1997cited by this paper
• Single focus of adenocarcinoma in the prostate biopsy specimen is not predictive of the pathologic stage of disease.

  1996cited by this paper
• Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues

  1995cited by this paper
• Failure of focal prostate cancer on biopsy to predict focal prostate cancer: the importance of prevalence.

  1995cited by this paper
• Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

  1995cited by this paper
• The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.

  1995cited by this paper
• Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

  1994cited by this paper
• Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer.

  1989cited by this paper

• The Predictive Value of Prostate Specific Antigen Density, Percentage Free Prostate Specific Antigen and the Combination for Prostate Cancer Detection in Grey Zone

  2025cites this paper
• MRI Pathway for Small Volume Prostate Gland Index Lesions; A Single Center Retrospective Analysis.

  2025cites this paper
• UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging.

  2022cites this paper
• NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ® ) Prostate Cancer Early Detection Version 1 . 2022 —

  2022cites this paper
• Comparison of three guidelines for screening, diagnosis and staging of prostate cancer in the USA and Europe

  2021cites this paper
• Advances in the diagnostic options for prostate cancer

  2020cites this paper
• Diagnosis of prostate cancer: the implications and proper utilization of PSA and its variants; indications and use of MRI and biomarkers.

  2020cites this paper
• Benign Prostatic Hyperplasia

  2020cites this paper
• Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• Diagnostic Value of ERG in Prostate Needle Biopsies Containing Minute Cancer Foci

  2017cites this paper
• Urological Association recommendations on prostate cancer screening and early diagnosis

  2017cites this paper
• Canadian Urological Association recommendations on prostate cancer screening and early diagnosis

  2017cites this paper
• Recommandations de l'Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.

  2017cites this paper
• Active surveillance or radical prostatectomy? Which treatment is best?

  2016influential citation
• Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria

  2016cites this paper
• NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ® ) Prostate Cancer Early Detection

  2016cites this paper
• Transperineal template‐guided mapping biopsy of the prostate

  2015cites this paper
• Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?

  2015cites this paper
• Integrated US-MR fusion images and MR targeted biopsies. What are their role and value in the detection and follow-up of prostate cancer.

  2015cites this paper
• Clinical significance of single microscopic focus of adenocarcinoma at prostate biopsy

  2015cites this paper
• NCCN Guidelines Version 2 . 2017 Table of Contents Prostate Cancer Early Detection

  2015cites this paper
• Prevalence of high-grade or insignificant prostate cancer in Korean men with prostate-specific antigen levels of 3.0-4.0 ng/mL.

  2015cites this paper
• Prostate Cancer Early Detection Panel Members

  2015cites this paper
• Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?

  2015cites this paper
• Prostate Cancer Early Detection, Version 2.2015

  2015cites this paper
• Combination of clinical characteristics and transrectal ultrasound-guided biopsy to predict lobes without significant cancer: application in patient selection for hemiablative focal therapy

  2014cites this paper
• PSA density improves prediction of prostate cancer.

  2014cites this paper
• Prostatakrebs mit einzelnen Foki: Aktueller Stand der Diagnose und Behandlung

  2014cites this paper
• [Clinical characterization of prostate cancer potentially insignificant in the prostate biopsy].

  2013cites this paper
• Caracterización clínica del cáncer de próstata potencialmente insignificante en la biopsia prostática

  2013cites this paper
• Method for sampling tissue for research which preserves pathological data in radical prostatectomy

  2013cites this paper
• Single Foci Prostate Cancer: Current Diagnosis and Management

  2013cites this paper
• Clinical characterization of prostate cancer potentially insignificant in the prostate biopsy

  2013cites this paper
• Is it possible to predict low‐volume and insignificant prostate cancer by core needle biopsies?

  2013cites this paper
• Re: Prediction of Erectile Function Following Treatment Certain observations in the study by Alemozaffar et al are for Prostate Cancer

  2012cites this paper
• Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?

  2012cites this paper
• The accuracy of pathological data for the prediction of insignificant prostate cancer.

  2012cites this paper
• Is prostate cancer screening worthy in southern European male populations? A case study in Eleusina, Greece.

  2012cites this paper
• Are Clinically Insignificant Prostate Cancers Really Insignificant among Korean Men?

  2012cites this paper
• Prostate-specific antigen velocity (PSAV) and PSAV per initial volume (PSAVD) for early detection of prostate cancer in Chinese men.

  2012cites this paper
• “Is Prostate Cancer Screening Worthy in Southern European Male Populations? A Case Study in Eleusina, Greece: Prostate Cancer Screening in Eleusina

  2012cites this paper
• Patienteninformation aus Sicht der Klinik und im Praxisalltag

  2012cites this paper
• Is PCA3 Score Useful in Preoperative Staging of a Single Microfocus of Prostate Cancer Diagnosed at Saturation Biopsy

  2012cites this paper
• Re: Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection.

  2012cites this paper
• Potential predictive factors of positive prostate biopsy in the Chinese population

  2012cites this paper
• The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancer.

  2011cites this paper
• Minimal or no residual prostatic adenocarcinoma on radical prostatectomy: a 5-year experience with "vanishing carcinoma phenomenon".

  2011cites this paper
• NCCN Guidelines Version 1 . 2014 Prostate Cancer Early Detection

  2011cites this paper
• pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies

  2011cites this paper
• Predictive preoperatory variables of the prostate tumor volume.

  2011cites this paper
• The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer.

  2011cites this paper
• Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.

  2011cites this paper
• Error rates in reporting prostatic core biopsies

  2011cites this paper
• Molecular pathology of prostate cancer

  2011cites this paper
• Prediction of pathological outcomes for a single microfocal (≤3 mm) Gleason 6 prostate cancer detected via contemporary multicore (≥12) biopsy in men with prostate‐specific antigen ≤10 ng/mL

  2011cites this paper
• Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.

  2010cites this paper
• Detection rates of nonpalpable prostate cancer in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/mL.

  2010cites this paper
• Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men

  2010cites this paper
• Pathological findings at radical prostatectomy in Japanese prospective active surveillance cohort.

  2010cites this paper
• Is a Single Focus of Low-Grade Prostate Cancer Diagnosed on Saturation Biopsy Predictive of Clinically Insignificant Cancer?

  2010cites this paper
• Validation of Epstein criteria of insignificant prostate cancer in Middle East patients

  2010cites this paper
• Monocyte chemotactic protein‐1 (MCP‐1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia

  2010cites this paper
• ‘Insignificant’ prostate cancer on prostatectomy and cystoprostatectomy: variation on a theme ‘low‐volume/ low‐grade’ prostate cancer?

  2010cites this paper
• NCCN clinical practice guidelines in oncology: prostate cancer early detection.

  2010cites this paper
• Prostate cancer early detection

  2010cites this paper
• [Diffusion-weighted MR imaging of the prostate].

  2010cites this paper
• A clinical dilemma; single prostatic cancer focus in biopsy. Interpretation and management.

  2010cites this paper
• False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-up

  2010cites this paper
• IRM de diffusion de la prostate

  2010cites this paper
• Relationship between preoperative PSA, PSA density, free/total PSA ratio and unfavorable pathological features of surgical specimen and biochemical failure in patients who have undergone radical prostatectomy

  2010cites this paper
• Overview Prostate cancer is the most commonly diagnosed The NCCN Prostate Cancer Early Detection Clinical Practice Guidelines in OncologyTM

  2010cites this paper
• Preoperative Prediction of Pathologically Insignificant Prostate Cancer in Radical Prostatectomy Specimens: The Role of Prostate Volume and the Number of Positive Cores

  2010cites this paper
• Prostate cancer : the clinical relevance of pathological findings after radical prostatectomy

  2009influential citation
• Saturation biopsies for prostate cancer: current uses and future prospects

  2009cites this paper
• Modified Gleason grading. An updated review.

  2009cites this paper
• Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen

  2009cites this paper
• Biological aggressiveness of prostate cancer in the Finnish screening trial

  2009cites this paper
• Non-surgical treatment of localised prostate cancer.

  2009cites this paper
• Clinicopathological behavior of single focus prostate adenocarcinoma.

  2009cites this paper
• A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or "insignificant".

  2009cites this paper
• Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

  2009cites this paper
• Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.

  2008cites this paper
• Zur klinischen Insignifikanz des Prostatakarzinoms

  2008cites this paper
• Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy.

  2008cites this paper
• The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4–10 ng/mL

  2008cites this paper
• The clinical management of patients with a small volume of prostatic cancer on biopsy: What are the risks of progression?

  2008cites this paper
• LOW‐RISK LOCALIZED PROSTATE CANCER: ARE WE READY TO TELL PATIENTS THAT ACTIVE SURVEILLANCE IS THE PREFERRED OPTION?

  2008cites this paper
• Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation

  2008cites this paper
• Should patients consider active surveillance?

  2008cites this paper
• A clinicopathologic study of preoperative and postoperative findings with minute Gleason 3+3=6 cancer at radical prostatectomy.

  2008cites this paper
• A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy--can we predict adverse pathological outcomes?

  2008cites this paper
• Cncer de prstata insignificante: Anlisis de nuestra serie

  2008cites this paper
• Single Prostatic Cancer Foci on Prostate Biopsy

  2008cites this paper
• The Diagnostic Value of Predictive Factors for Clinically Insignificant Prostate Cancer

  2008cites this paper
• Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer.

  2008cites this paper
• [Insignificant prostate cancer. Analysis our series].

  2008cites this paper
• Significance of minute focus of adenocarcinoma on prostate needle biopsy.

  2007cites this paper
• [Prognosis and predictive factors of prostate cancer in the prostatic biopsy].

  2007cites this paper
• Factores pronósticos y predictivos del carcinoma de próstata en la biopsia prostática

  2007cites this paper
• Place de ľéchographie de contraste dans la détection et le bilan ďextension du cancer prostatique

  2007cites this paper